Medindia

X

Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer

Wednesday, December 9, 2009 Corporate News J E 4
Advertisement


BALTIMORE, Dec. 8 Ameritox, the U.S. leader in pain medication monitoring solutions, has announced the appointment of Jay B. Zimmerman as Chief Operating Officer. Zimmerman will oversee R&D, infrastructure and expansion initiatives, including driving efficiencies within existing operations, overseeing the development of new technologies, and ensuring process standardization and quality control across all facilities, including the Midland, TX laboratory and the new laboratory opening in Greensboro, NC in 2010. Jay joined Ameritox on September 1, 2009 and will be based at its headquarters in Baltimore, MD.

"Jay is bringing his expertise in building high quality infrastructure and scalability to bear at a critical moment in our growth," said Ancelmo E. Lopes, CEO of Ameritox. "We welcome his leadership as we expand processing capacity with our new laboratory in North Carolina and prepare to launch new technologies that will enhance our current offerings, furthering our ability to provide physicians with critical tools to achieve optimal patient outcomes in Pain Medication Monitoring."

For more than 20 years, Mr. Zimmerman has managed clinical research programs in a variety of settings. He began his career at Massachusetts General Hospital, the flagship Harvard University Hospital, where he served as Administrative Director in the Center for Imaging and Pharmaceutical Research. Mr. Zimmerman was later appointed Senior Vice President and Chief Operating Officer of WorldCare, Inc., a clinical research organization serving Proctor & Gamble, Hoffmann La Roche, Novartis and other leading pharmaceutical companies.

At Perceptive Informatics, Inc., a subsidiary of the biopharmaceutical services provider PAREXEL International, Jay served as Vice President of the Medical Imaging Division. During his tenure there he oversaw the company's contract research and consulting services for pharmaceutical, biotechnology and medical device customers in their use of medical imaging as an endpoint in clinical trials - contributing to dozens of successful regulatory submissions.

Most recently Mr. Zimmerman founded North Point Imaging Research, a start up venture providing technology and services using medical imaging as an endpoint in the clinical development process.

Jay Zimmerman received his Masters of Education in Administrative Policies Studies, Hospital Administration from the University of Pittsburgh, and a Bachelor of Science in Biology/Education from the University of South Carolina.

About Ameritox

Ameritox is the nation's leader in pain medication monitoring solutions(SM), offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provide physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers Rx Guardian(SM), the most thorough and personalized lab service available and the only pain medication testing program with a proprietary methodology to help physicians assess whether patients are taking their pain medication as directed. Medication monitoring helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore, MD, with laboratory facilities in Midland, TX and a second laboratory opening early 2010 in Greensboro NC.

AMERITOX, the AMERITOX logo, RX GUARDIAN and PROTECT YOUR PATIENTS, PROTECT YOUR PRACTICE are trademarks of Ameritox.

Contact: Jennifer Paganelli of Edelman PR Worldwide, +1-347-658-8290

SOURCE Ameritox
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Hospitals Urged to Implement New Strategies Now or...
S
Landrieu, Stabenow, Small Business Owners to Discu...